Davinthra Thillainathan

Stock Analyst at Goldman Sachs

(1.08)
# 3,658
Out of 4,455 analysts
35
Total ratings
38.1%
Success rate
-3.2%
Average return

Stocks Rated by Davinthra Thillainathan

Integral Diagnostics Limited
Jun 1, 2026
Upgraded: Hold
Price Target: $2.10$2.15
Current: $2.00
Upside: +7.50%
Ansell Limited
Apr 7, 2026
Initiated Coverage: Hold
Price Target: $31.80
Current: $31.47
Upside: +1.05%
Fisher & Paykel Healthcare Corporation Limited
Feb 23, 2026
Maintained: Buy
Price Target: $52.33$53.92
Current: $38.45
Upside: +40.24%
ResMed Inc.
Feb 2, 2026
Maintained: Buy
Price Target: $49.30$53.20
Current: $28.94
Upside: +83.83%
CSL Limited
Oct 29, 2025
Maintained: Buy
Price Target: $304.60$212.10
Current: $114.87
Upside: +84.64%
Nanosonics Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $7.11
Current: $3.22
Upside: +120.79%
Ramsay Health Care Limited
Sep 11, 2025
Maintained: Hold
Price Target: n/a
Current: $43.10
Upside: -
Healius Limited
Aug 12, 2025
Maintained: Sell
Price Target: $1.20$0.80
Current: $0.365
Upside: +119.18%
Cochlear Limited
Jun 14, 2025
Maintained: Hold
Price Target: n/a
Current: $118.03
Upside: n/a
Sonic Healthcare Limited
Apr 3, 2025
Initiated Coverage: Buy
Price Target: $32.20
Current: $20.42
Upside: n/a
Initiated Coverage: Hold
Price Target: $3.30
Current: $2.22
Upside: n/a